BIOMARKERS TO PREDICT TACE TREATMENT EFFICACY FOR HEPATOCELLULAR CARCINOMA

摘要

The present invention relates to hepatoma diagnosis and, more specifically, to a biomarker for predicting the prognosis of trans arterial chemo embolization (TACE). The biomarker uses a multiple reaction monitoring (MRM) technique and thus can predict the prognosis of the TACE while the biomarker is multiple screening in a short time and has high accuracy and sensitivity.